W. M. Linehan

903 total citations
12 papers, 690 citations indexed

About

W. M. Linehan is a scholar working on Pulmonary and Respiratory Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, W. M. Linehan has authored 12 papers receiving a total of 690 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 4 papers in Endocrinology, Diabetes and Metabolism and 3 papers in Surgery. Recurrent topics in W. M. Linehan's work include Prostate Cancer Treatment and Research (4 papers), Adrenal and Paraganglionic Tumors (3 papers) and Renal cell carcinoma treatment (2 papers). W. M. Linehan is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Adrenal and Paraganglionic Tumors (3 papers) and Renal cell carcinoma treatment (2 papers). W. M. Linehan collaborates with scholars based in United States, Italy and France. W. M. Linehan's co-authors include Paul H. Duray, Michael R. Emmert‐Buck, Zhenping Zhuang, David G. Bostwick, Cathy D. Vocke, Rudy Pozzatti, Lance A. Liotta, David Köhler, Elizabeth C. Jones and Clara C. Chen and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and The Journal of Urology.

In The Last Decade

W. M. Linehan

12 papers receiving 672 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
W. M. Linehan United States 7 359 243 229 150 125 12 690
Lori Rink United States 18 423 1.2× 365 1.5× 183 0.8× 195 1.3× 115 0.9× 33 960
Kerry D. Lynch United States 6 319 0.9× 352 1.4× 233 1.0× 137 0.9× 285 2.3× 7 887
Tiziano Camacci Italy 14 241 0.7× 264 1.1× 146 0.6× 113 0.8× 276 2.2× 18 814
Vanessa Cerisano Italy 11 318 0.9× 396 1.6× 163 0.7× 42 0.3× 183 1.5× 11 750
Markus Mayrhofer Sweden 12 176 0.5× 153 0.6× 181 0.8× 105 0.7× 101 0.8× 21 506
Diana Zambelli Italy 11 331 0.9× 585 2.4× 165 0.7× 46 0.3× 203 1.6× 11 910
Susanne V. Allander Sweden 12 257 0.7× 302 1.2× 115 0.5× 93 0.6× 140 1.1× 18 728
Vasily J. Assikis United States 12 328 0.9× 233 1.0× 145 0.6× 205 1.4× 216 1.7× 21 728
Peter C. Haughney United States 13 350 1.0× 323 1.3× 86 0.4× 76 0.5× 115 0.9× 20 715
Joana Vieira Portugal 14 293 0.8× 344 1.4× 134 0.6× 85 0.6× 220 1.8× 39 701

Countries citing papers authored by W. M. Linehan

Since Specialization
Citations

This map shows the geographic impact of W. M. Linehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. M. Linehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. M. Linehan more than expected).

Fields of papers citing papers by W. M. Linehan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by W. M. Linehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. M. Linehan. The network helps show where W. M. Linehan may publish in the future.

Co-authorship network of co-authors of W. M. Linehan

This figure shows the co-authorship network connecting the top 25 collaborators of W. M. Linehan. A scholar is included among the top collaborators of W. M. Linehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with W. M. Linehan. W. M. Linehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Srinivasan, Ramaprasad, Othon Iliopoulos, W. Kimryn Rathmell, et al.. (2022). LBA69 Belzutifan, a HIF-2α Inhibitor, for von Hippel-Lindau (VHL) disease-associated neoplasms: 36 months of follow-up of the phase II LITESPARK-004 study. Annals of Oncology. 33. S1433–S1434. 10 indexed citations
2.
Boyce, Alison M, William H Chong, Thomas H. Shawker, et al.. (2012). Characterization and Management of Testicular Pathology in McCune-Albright Syndrome. The Journal of Clinical Endocrinology & Metabolism. 97(9). E1782–E1790. 49 indexed citations
3.
Shuch, Brian, Gennady Bratslavsky, Joanna H. Shih, et al.. (2011). Impact of pathologic tumor characteristics in patients with sarcomatoid renal cell carcinoma.. Journal of Clinical Oncology. 29(7_suppl). 343–343. 1 indexed citations
4.
Linehan, W. M., et al.. (2006). Partial Adrenalectomy: The National Cancer Institute Experience. The Journal of Urology. 175(3). 894–894. 3 indexed citations
5.
Menefee, Max G., Herb Kotz, Manish Agrawal, et al.. (2004). A phase II clinical trial of BMS-247550 (ixabepilone), a microtubule-stabilizing agent in renal cell cancer. Journal of Clinical Oncology. 22(14_suppl). 4550–4550. 6 indexed citations
6.
Figg, W D, William Dahut, Paul H. Duray, et al.. (2001). A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.. PubMed. 7(7). 1888–93. 243 indexed citations
7.
Cheng, Liang, T G Pretlow, Fadi W. Abdul‐Karim, et al.. (1999). Evidence of Independent Origin of Multiple Tumors From Patients With Prostate Cancer. The Journal of Urology. 161(1). 352–353. 25 indexed citations
8.
Bauer, Kenneth S., William D. Figg, John M. Hamilton, et al.. (1999). A pharmacokinetically guided phase II study of CAI in androgen-independent prostate cancer. 1 indexed citations
9.
Emmert‐Buck, Michael R., Cathy D. Vocke, Rudy Pozzatti, et al.. (1995). Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia.. PubMed. 55(14). 2959–62. 223 indexed citations
10.
Maurea, Simone, Alberto Cuocolo, J C Reynolds, et al.. (1993). Iodine-131-metaiodobenzylguanidine scintigraphy in preoperative and postoperative evaluation of paragangliomas: comparison with CT and MRI.. PubMed. 34(2). 173–9. 107 indexed citations
11.
Ashby, Helen, et al.. (1989). The Inhibition of Human Adrenal Steroidogenic Enzyme Activities by Suramin*. The Journal of Clinical Endocrinology & Metabolism. 68(2). 505–508. 21 indexed citations
12.
Choyke, Peter L., J A Frank, Andrew J. Dwyer, et al.. (1986). MR imaging of renal carcinoma: A comparison of techniques. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026